Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meggan Mackay

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Nature Clinical Practice. Rheumatology|January 18, 2008
Neuropsychiatric systemic lupus erythematosus reconsideredJorge Sánchez-Guerrero, Cynthia Aranow, Meggan Mackay, et al.
Plos One|June 3, 2009
Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosusAnnett M Jacobi, Jie Zhang, Meggan Mackay, et al.
Lupus|July 27, 2023
Hidden consequences: Uncovering belimumab's role in the development of <i>Pneumocystis jirovecii</i> pneumonia in a lupus patientMaria Ng, Meggan Mackay, Pranisha Gautam-Goyal, et al.
JCI Insight|July 22, 2025
Metabolic pathways within cTfh subsets and glucose-dependent activation of cTfh17 in SLE and healthy individualsVera Kim, Takaya Misao, Hong Tian, et al.
Arthritis and Rheumatism|May 29, 2007
Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritisMilena Pitashny, Noa Schwartz, Xiaoping Qing, et al.
The Journal of Rheumatology|July 5, 2005
Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infectionIftikhar A Chowdhry, Irene J Tan, Nabeela Mian, et al.
Journal of Immunological Methods|August 21, 2008
Identification of DNA-reactive B cells in patients with systemic lupus erythematosusJie Zhang, Annett M Jacobi, Meggan Mackay, et al.
Lupus|April 25, 2024
Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot studyErik W Anderson, Marissa Sansone, Bhakti Shah, et al.
Lupus Science & Medicine|December 3, 2015
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis TrialFarah Tamirou, Bernard R Lauwerys, Maria Dall'Era, et al.
The Journal of Experimental Medicine|August 23, 2006
Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLEMeggan Mackay, Anfisa Stanevsky, Tao Wang, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Nature Clinical Practice. Rheumatology|January 18, 2008
Neuropsychiatric systemic lupus erythematosus reconsideredJorge Sánchez-Guerrero, Cynthia Aranow, Meggan Mackay, et al.
Plos One|June 3, 2009
Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosusAnnett M Jacobi, Jie Zhang, Meggan Mackay, et al.
Lupus|July 27, 2023
Hidden consequences: Uncovering belimumab's role in the development of <i>Pneumocystis jirovecii</i> pneumonia in a lupus patientMaria Ng, Meggan Mackay, Pranisha Gautam-Goyal, et al.
JCI Insight|July 22, 2025
Metabolic pathways within cTfh subsets and glucose-dependent activation of cTfh17 in SLE and healthy individualsVera Kim, Takaya Misao, Hong Tian, et al.
Arthritis and Rheumatism|May 29, 2007
Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritisMilena Pitashny, Noa Schwartz, Xiaoping Qing, et al.
The Journal of Rheumatology|July 5, 2005
Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infectionIftikhar A Chowdhry, Irene J Tan, Nabeela Mian, et al.
Journal of Immunological Methods|August 21, 2008
Identification of DNA-reactive B cells in patients with systemic lupus erythematosusJie Zhang, Annett M Jacobi, Meggan Mackay, et al.
Lupus|April 25, 2024
Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot studyErik W Anderson, Marissa Sansone, Bhakti Shah, et al.
Lupus Science & Medicine|December 3, 2015
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis TrialFarah Tamirou, Bernard R Lauwerys, Maria Dall'Era, et al.
The Journal of Experimental Medicine|August 23, 2006
Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLEMeggan Mackay, Anfisa Stanevsky, Tao Wang, et al.
Pageof 10